ea0090rc4.5 | Rapid Communications 4: Reproductive and Developmental Endocrinology | ECE2023
Livadas Sarantis
, Goulis Dimitrios
, eBelardinelli Elisabetta
, Armeni Elena
, Solmi Beatrice
, Veneti Stavroula
, Lambrinoudaki Irene
, Cecchetti Carolina
, Macut Djuro P.
, Gambineri Alessandra
Heterozygotes carrying CYP21A2 gene mutations are found in 5-10% of the general population in Mediterranean countries. Accumulating data suggest a survival advantage of this population, despite the fact that carriers of two mutations suffer from either classical or non-classical congenital adrenal hyperplasia (NC-CAH), an entity with increased mortality. In an attempt to elaborate on this issue we evaluated females of reproductive age with CYP21A2 heterozygocity (HET). We have...